Better Therapeutics (NASDAQ:BTTX) reported quarterly losses of $(0.71) per share.
Wedbush Maintains Outperform on Wingstop, Raises Price Target to $157
Wedbush analyst Nick Setyan maintains Wingstop (NASDAQ:WING) with a Outperform and raises the price target from $135 to $157.